Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury

Cell Transplantation

Volumn 23, Issue 7, 2014, Pages 889-899

  Tsuda, Hidetoshi ^a,b   Yamahara, Kenichi ^b   Otani, Kentaro ^b   Okumi, Masayoshi ^a   Yazawa, Koji ^a   Kaimori, Jun Ya ^a   Taguchi, Akihiko ^b,c   Kangawa, Kenji ^b   Ikeda, Tomoaki ^b,d   Takahara, Shiro ^a   Isaka, Yoshitaka ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute kidney injury (AKI); Cell therapy; Fetal membrane (FM)

Indexed keywords

CREATININE; INTERLEUKIN 10; NEUTRALIZING ANTIBODY;

ACUTE KIDNEY FAILURE; ALLERGIC GLOMERULONEPHRITIS; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUGUST COPENHAGEN IRISH RAT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FETUS MEMBRANE; HISTOPATHOLOGY; KIDNEY FUNCTION; LEWIS RAT; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; REPERFUSION INJURY; T LYMPHOCYTE; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ALLOTRANSPLANTATION; ANIMAL; BLOOD; COMPLICATION; CYTOLOGY; EMBRYO MEMBRANE; IMMUNOLOGY; KIDNEY; MACROPHAGE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; ANTIBODIES, NEUTRALIZING; BLOOD UREA NITROGEN; CREATININE; EXTRAEMBRYONIC MEMBRANES; FEMALE; INTERLEUKIN-10; KIDNEY; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, INBRED ACI; RATS, INBRED LEW; REPERFUSION INJURY; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84902519174     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368913X665594     Document Type: Article

References (47)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4): 1815-1822; 2005.
2. Ascon, D. B.; Lopez-Briones, S.; Liu, M.; Ascon, M.; Savransky, V.; Colvin, R. B.; Soloski, M. J.; Rabb, H. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J. Immunol. 177(5): 3380-3387; 2006.
3. Augello, A.; Tasso, R.; Negrini, S. M.; Cancedda, R.; Pennesi, G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collageninduced arthritis. Arthritis Rheum. 56(4): 1175-1186; 2007.
4. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30(1): 42-48; 2002.
5. Bi, B.; Schmitt, R.; Israilova, M.; Nishio, H.; Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18(9): 2486-2496; 2007.
6. Block, C. A.; Schoolwerth, A. C. The epidemiology and outcome of acute renal failure and the impact on chronic kidney disease. Semin. Dial. 19(6): 450-454; 2006.
7. Bouffi, C.; Bony, C.; Courties, G.; Jorgensen, C.; Noel, D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5(12): e14247; 2010.
8. Burne, M. J.; Daniels, F.; El Ghandour, A.; Mauiyyedi, S.; Colvin, R. B.; O'Donnell, M. P.; Rabb, H. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108(9): 1283-1290; 2001.
9. Caterson, E. J.; Nesti, L. J.; Danielson, K. G.; Tuan, R. S. Human marrow-derived mesenchymal progenitor cells: Isolation, culture expansion, and analysis of differentiation. Mol. Biotechnol. 20(3): 245-256; 2002.
10. Chamberlain, G.; Fox, J.; Ashton, B.; Middleton, J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11): 2739-2749; 2007.
11. Demeure, C. E.; Yang, L. P.; Desjardins, C.; Raynauld, P.; Delespesse, G. Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 27(12): 3526-3531; 1997.
12. Deng, J.; Kohda, Y.; Chiao, H.; Wang, Y.; Hu, X.; Hewitt, S. M.; Miyaji, T.; McLeroy, P.; Nibhanupudy, B.; Li, S.; Star, R. A. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 60(6): 2118-2128; 2001.
13. deVries, J. E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27(5): 537-541; 1995.
14. DuBose, Jr., T. D.; Warnock, D. G.; Mehta, R. L.; Bonventre, J. V.; Hammerman, M. R.; Molitoris, B. A.; Paller, M. S.; Siegel, N. J.; Scherbenske, J.; Striker, G. E. Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am. J. Kidney Dis. 29(5): 793-799; 1997.
15. Friedewald, J. J.; Rabb, H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 66(2): 486-491; 2004.
16. Furuichi, K.; Shintani, H.; Sakai, Y.; Ochiya, T.; Matsushima, K.; Kaneko, S.; Wada, T. Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Clin. Exp. Nephrol. 16(5): 679-689; 2012.
17. Furuichi, K.; Wada, T.; Iwata, Y.; Kitagawa, K.; Kobayashi, K.; Hashimoto, H.; Ishiwata, Y.; Asano, M.; Wang, H.; Matsushima, K.; Takeya, M.; Kuziel. W. A.; Mukaida, N; Yokoyama, H. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J. Am. Soc. Nephrol. 14(10): 2503-2515; 2003.
18. Gonzalez-Rey, E.; Anderson, P.; Gonzalez, M. A.; Rico, L.; Buscher, D.; Delgado, M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58(7): 929-939; 2009.
19. Herrera, M. B.; Bussolati, B.; Bruno, S.; Fonsato, V.; Romanazzi, G. M.; Camussi, G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int. J. Mol. Med. 14(6): 1035-1041; 2004.
20. Herrera, M. B.; Bussolati, B.; Bruno, S.; Morando, L.; Mauriello-Romanazzi, G.; Sanavio, F.; Stamenkovic, I.; Biancone, L.; Camussi, G. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 72(4): 430-441; 2007.
21. Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; de Groot-Swings, G. M.; Claas, F. H.; Fibbe, W. E.; Kanhai, H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22(7): 1338-1345; 2004.
22. Ishikane, S.; Ohnishi, S.; Yamahara, K.; Sada, M.; Harada, K.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Kitamura, S.; Nagaya, N.; Ikeda, T. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26(10): 2625-2633; 2008.
23. Ishikane, S.; Yamahara, K.; Sada, M.; Harada, K.; Kodama, M.; Ishibashi-Ueda, H.; Hayakawa, K.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Kangawa, K.; Ikeda, T. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J. Mol. Cell. Cardiol. 49(5): 753-761; 2010.
24. Lai, L. W.; Yong, K. C.; Igarashi, S.; Lien, Y. H. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int. 71(12): 1223-1231; 2007.
25. Lange, C.; Togel, F.; Ittrich, H.; Clayton, F.; Nolte-Ernsting, C.; Zander, A. R.; Westenfelder, C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 68(4): 1613-1617; 2005.
26. Morigi, M.; Imberti, B.; Zoja, C.; Corna, D.; Tomasoni, S.; Abbate, M.; Rottoli, D.; Angioletti, S.; Benigni, A.; Perico, N.; Alison, M.; Remuzzi, G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 15(7): 1794-1804; 2004.
27. Morigi, M.; Introna, M.; Imberti, B.; Corna, D.; Abbate, M.; Rota, C.; Rottoli, D.; Benigni, A.; Perico, N.; Zoja, C.; Rambaldi, A.; Remuzzi, A.; Remuzzi, G. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26(8): 2075-2082; 2008.
28. Nemeth, K.; Leelahavanichkul, A.; Yuen, P. S.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P. G.; Leelahavanichkul, K.; Koller, B. H.; Brown, J. M.; Hu, X.; Jelinek, I.; Star, R. A.; Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15(1): 42-49; 2009.
29. Oh-ishi, S.; Utsunomiya, I.; Yamamoto, T.; Komuro, Y.; Hara, Y. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur. J. Pharmacol. 300(3): 255-259; 1996.
30. Ortiz, L. A.; Gambelli, F.; McBride, C.; Gaupp, D.; Baddoo, M.; Kaminski, N.; Phinney, D. G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100(14): 8407-8411; 2003.
31. Pajkrt, D.; Camoglio, L.; Tiel-van Buul, M. C.; de Bruin, K.; Cutler, D. L.; Affrime, M. B.; Rikken, G.; van der Poll, T.; ten Cate, J. W.; van Deventer, S. J. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration. J. Immunol. 158(8): 3971-3977; 1997.
32. Perretti, M.; Szabo, C.; Thiemermann, C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116(4): 2251-2257; 1995.
33. Persy, V. P.; Verhulst, A.; Ysebaert, D. K.; De Greef, K. E.; De Broe, M. E. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int. 63(2): 543-553; 2003.
34. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147; 1999.
35. Portmann-Lanz, C. B.; Schoeberlein, A.; Huber, A.; Sager, R.; Malek, A.; Holzgreve, W.; Surbek, D. V. Placental mesenchymal stem cells as potential autologous graft for preand perinatal neuroregeneration. Am. J. Obstet. Gynecol. 194(3): 664-673; 2006.
36. Rabb, H.; Daniels, F.; O'Donnell, M.; Haq, M.; Saba, S. R.; Keane, W.; Tang, W. W. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279(3): F525-531; 2000.
37. Savransky, V.; Molls, R. R.; Burne-Taney, M.; Chien, C. C.; Racusen, L.; Rabb, H. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int. 69(2): 233-238; 2006.
38. Shah, S. H.; Mehta, R. L. Acute kidney injury in critical care: Time for a paradigm shift? Curr. Opin. Nephrol. Hypertens. 15(6): 561-565; 2006.
39. Strassmann, G.; Patil-Koota, V.; Finkelman, F.; Fong, M.; Kambayashi, T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180(6): 2365-2370; 1994.
40. Takada, M.; Nadeau, K. C.; Shaw, G. D.; Marquette, K. A.; Tilney, N. L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99(11): 2682-2690; 1997.
41. Togel, F.; Hu, Z.; Weiss, K.; Isaac, J.; Lange, C.; Westenfelder, C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal. Physiol. 289(1): F31-42; 2005.
42. Tonelli, M.; Manns, B.; Feller-Kopman, D. Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am. J. Kidney Dis. 40(5): 875-885; 2002.
43. Tsuda, H.; Yamahara, K.; Ishikane, S.; Otani, K.; Nakamura, A.; Sawai, K.; Ichimaru, N.; Sada, M.; Taguchi, A.; Hosoda, H. Tsuji, M.; Kawachi, H.; Horio, M.; Isaka, Y.; Kangawa, K.; Takahara, S.; Ikeda, T. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. Am. J. Physiol. Renal. Physiol. 299(5): F1004-1013; 2011.
44. Venkataraman, R.; Kellum, J. A. Novel approaches to the treatment of acute renal failure. Expert Opin. Investig. Drugs 12(8): 1353-1366; 2003.
45. Wong, R. K.; Hagg, E. U.; Rabie, A. B.; Lau, D. W. Bone induction in clinical orthodontics: A review. Int. J. Adult Orthodon. Orthognath. Surg. 17(2): 140-149; 2002.
46. Yokota, N.; Daniels, F.; Crosson, J.; Rabb, H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 74(6): 759-763; 2002.
47. Ysebaert, D. K.; De Greef, K. E.; Vercauteren, S. R.; Ghielli, M.; Verpooten, G. A.; Eyskens, E. J.; De Broe, M. E. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol. Dial. Transplant. 15(10): 1562-1574; 2000.